13G Filing: Scopia Capital Raises Stake in Insys Therapeutics, Inc. (INSY)

Page 6 of 12

Page 6 of 12 SEC Filing

CUSIP No.
45824V209
Item 1.
(a).
Name of Issuer:
Insys Therapeutics, Inc.
(b).
Address of Issuer’s Principal Executive Offices:
1333 S. Spectrum Blvd, Suite 100
Chandler, Arizona 85286
Item 2.
(a).
Name of Person Filing:
Scopia Capital Management LP
Scopia Management, Inc.
Matthew Sirovich
Jeremy Mindich
(b).
Address or Principal Business Office or, if None, Residence:
Scopia Capital Management LP
152 West 57th Street, 33rd Floor
New York, NY 10019
Scopia Management, Inc.
Matthew Sirovich
Jeremy Mindich
c/o Scopia Capital Management LP
152 West 57th Street, 33rd Floor
New York, NY 10019
(c).
Citizenship:
Scopia Capital Management LP – Delaware limited partnership
Scopia Management, Inc. – New York corporation
Matthew Sirovich – United States citizen
Jeremy Mindich – United States citizen
(d).
Title of Class of Securities:
Common Stock, $0.01 par value
(e).
CUSIP Number:
45824V209
Item 3.
If this statement is filed pursuant to §§.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a:
(a)
[_]
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
(b)
[_]
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c)
[_]
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d)
[_]
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e)
[X]
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
[_]
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
[X]
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
(h)
[_]
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);
(i)
[_]
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
[_]
A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
(k)
[_]
Group, in accordance with §240.13d-1(b)(1)(ii)(K).  If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:

Follow Insys Therapeutics Inc. (NASDAQ:INSY)

Page 6 of 12